Parkinsonian striatal acetylcholine dynamics are refractory to L-DOPA treatment
Potjer, E. V.; Wu, X.; Kane, A. N.; Parker, J. G.
Show abstract
BackgroundFluctuations in striatal dopamine (DA) are interdependent with fluctuations in acetylcho- line (ACh), both of which are thought to be important for motor function and dysfunction in Parkinsons disease (PD). ObjectivesDetermine how ACh dynamics are altered by dopamine under normal and parkinsonian conditions following acute and chronic L-DOPA treatment. MethodsWe used fiber photometry to record fluorescent DA and ACh sensors in the dorsomedial striatum (DMS) of normal mice treated with vehicle or amphetamine and in the dorsolateral striatum (DLS) of mice with unilateral substantia nigra (SNc) DA neuron lesions (using 6-OHDA) subjected to an L-DOPA-induced dyskinesia (LID) protocol. ResultsUnder normal conditions, ACh exhibited transient increases followed by pauses and fluctuated at [~]1-Hz frequency in an anti-correlated manner to DA. Amphetamine treatment reduced the frequency of ACh fluctuations and amplitude of ACh transients while prolonging after-transient pauses. In 6-OHDA- lesioned mice, ACh dynamics oscillated at a higher frequency, and ACh events had reduced peaks and pauses. L-DOPA increased DA and, after repeated treatments, also reduced ACh. However, L-DOPA neither restored the anti-correlation between DA and ACh nor normalized the reduced ACh transient and pause amplitudes or the increased frequency of ACh fluctuations. In extended recordings during the tran- sition to the L-DOPA OFF state, ACh remained low as DA diminished, and ACh transient and pause amplitudes remained suppressed, and the oscillatory frequency elevated. ConclusionsDopamine depletion transforms striatal ACh dynamics and L-DOPA fails to normalize these dynamics. Because these dynamics are unresponsive to treatment, new therapies targeting them may offer symptomatic improvements for PD and LID. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=72 SRC="FIGDIR/small/686401v1_ufig1.gif" ALT="Figure 1"> View larger version (28K): org.highwire.dtl.DTLVardef@705b66org.highwire.dtl.DTLVardef@80afd2org.highwire.dtl.DTLVardef@972c41org.highwire.dtl.DTLVardef@da91f8_HPS_FORMAT_FIGEXP M_FIG C_FIG We used dual-wavelength fiber photometry to simultaneously record dopamine and acetylcholine dynam- ics in the dorsal striatum. We recorded these dynamics in control mice before and after treatment with the dopamine releaser amphetamine and in hemiparkinsonian mice before after treatment with the dopamine pre-cursor L-DOPA. We asked how these experimental manipulations alter the bulk signaling of dopa- mine and acetylcholine, their temporal relationship, and the sub-second dynamics of acetylcholine signaling.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Sensory responses in dorsolateral striatum are modulated by motor activity in a dopamine-dependent manner 97%
- Synaptotagmin-1-dependent phasic axonal dopamine release is dispensable for basic motor behaviors in mice. 96%
- VTA dopamine neurons are hyperexcitable in 3xTg-AD mice due to casein kinase 2-dependent SK channel dysfunction 95%
Similar papers in this journal
- Dopamine release in nucleus accumbens is under tonic inhibition by adenosine A1 receptors regulated by astrocytic ENT1 and dysregulated by ethanol 94%
- Cell-Type-Specific Decrease of the Intrinsic Excitability of Motor Cortical Pyramidal Neurons in Parkinsonism 94%
- Striatal Direct Pathway Targets Npas1+ Pallidal Neurons 94%
Similar papers in this journal
- Abnormal hyperactivity of specific striatal ensembles encodes distinct dyskinetic behaviors revealed by high-resolution clustering 96%
- Excessive Firing of Dyskinesia-Associated Striatal Direct Pathway Neurons is Gated By Dopamine and Excitatory Synaptic Input 95%
- Ca2+-dependent phosphodiesterase 1 regulates the plasticity of striatal spiny projection neuron glutamatergic synapses 95%
Similar papers in this journal
- State-dependent modulation of spiny projection neurons controls levodopa-induced dyskinesia in a mouse model of Parkinson's disease 97%
- The gut-brain vagal axis governs mesolimbic dopamine dynamics and reward events 96%
- Phosphoglycerate kinase 1 is a central leverage point in Parkinson's disease driven neuronal metabolic deficits 95%
Similar papers in this journal
- Alterations in the intrinsic properties of striatal cholinergic interneurons after dopamine lesion and chronic L-DOPA 96%
- Dopamine neuron morphology and output are differentially controlled by mTORC1 and mTORC2 96%
- Synaptic mechanisms modulate the spatiotemporal dynamics of striatal direct pathway neurons and motor output 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.